tiprankstipranks
Trending News
More News >
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF

Innate Pharma SA (IPHYF) Revenue

Compare
27 Followers

Innate Pharma SA Revenue

Innate Pharma SA had a revenue of 4.86M in the quarter ending Jun 30, 2025, with -37.50%. This bring the company's revenue in the last twelve months to 12.64M, Increased -37.20%. In the fiscal year ending Dec 31, 2024, Innate Pharma SA had annual revenue of 12.62M with -75.68% growth.
Revenue (ttm)
12.64M
Revenue Growth
P/S Ratio
13.43
Revenue/Employee
$69,735
Employees
181
Market Cap
$169.49M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
12.62M-39.28M+24.32%
Dec 31, 2023
51.90M2.26M+104.56%
Dec 31, 2022
49.64M37.53M+409.83%
Dec 31, 2021
12.11M-57.66M+17.36%
Dec 31, 2020
69.77M800.00K+101.16%
Dec 31, 2019
68.97M-10.92M+86.33%
Dec 31, 2018
79.89M47.26M+244.83%
Dec 31, 2017
32.63M-23.53M+58.10%
Dec 31, 2016
56.16M